tiprankstipranks
Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
PremiumPress ReleasesUnicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
1M ago
Unicycive Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Unicycive Therapeutics initiated with an Overweight at Piper Sandler
1M ago
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
2M ago
Unicycive Therapeutics presents on UNI-494 at AKI, CRRT conference
PremiumThe FlyUnicycive Therapeutics presents on UNI-494 at AKI, CRRT conference
2M ago
Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference
PremiumPress Releases
Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference
2M ago
Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)
PremiumPress Releases
Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)
2M ago
Unicycive Therapeutics Averts Nasdaq Delisting Concerns
PremiumCompany AnnouncementsUnicycive Therapeutics Averts Nasdaq Delisting Concerns
3M ago
Unicycive Therapeutics initiated with an Outperform at Noble Capital
PremiumThe Fly
Unicycive Therapeutics initiated with an Outperform at Noble Capital
3M ago
Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting
PremiumPress Releases
Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100